“Large nonprofit hospital systems have exploited taxpayer subsidies and regulatory loopholes while failing to deliver the public benefit they promise.”
Topic: United States Congress
bicameral legislature of the United States
Categories
Budget and Spending Conservatism Courts Culture Domestic Policy Economic Opportunity Economy Government Regulation Government Spending Infrastructure & Technology Legal and Judicial Life Markets and Finance Political Thought Poverty & Welfare Poverty and Inequality Progressivism Public Opinion Technology Transparency Updates
An Overdue Course Correction at the CFPB
Acting CFPB Director Russ Vought’s rollback of state enforcement overreach marks a critical return to legal restraint, restoring constitutional balance and regulatory clarity to America’s financial system.
Categories
Alaska Arizona California Colorado Culture Domestic Policy Economic Opportunity Economy Government Regulation Legal and Judicial Life Markets and Finance Nevada New Mexico Oklahoma Political Thought Poverty & Welfare Poverty and Inequality Public Opinion Texas The Constitution Top Issues Updates Utah
Fox Business: Credit card rewards are about to vanish, and guess who’s to blame?
This isn’t just about miles and points; it’s about economic freedom and financial choice.
Categories
Alaska Arizona California Colorado Conservatism Courts Culture Domestic Policy Economic Opportunity Economy Government Regulation Legal and Judicial Life Markets and Finance Nevada New Mexico Oklahoma Political Thought Poverty & Welfare Poverty and Inequality Progressivism Public Opinion Texas The Constitution Top Issues Updates Utah
American Banker: Death by a thousand caps—State laws could kill credit card rewards
A group of states are pursuing similar efforts to cap credit card interchange fees, endangering rewards programs that customers value, and raising concerns about an illegal interstate compact.
CFPB is doing more harm than good, and its dissolution is not just a policy preference but an economic necessity.
Categories
Alaska Arizona Budget and Spending California Colorado Conservatism Courts Domestic Policy Economic Opportunity Economy Government Regulation Government Spending Infrastructure & Technology Legal and Judicial Markets and Finance Nevada New Mexico Oklahoma Political Thought Poverty and Inequality Progressivism Public Opinion Texas Top Issues Updates Utah
The CFPB’s Desperate Eleventh-Hour Overreach
Rohit Chopra is lashing out with desperate, partisan overreach in his final days, prioritizing political agendas over consumer protection while creating regulatory chaos and undermining the legitimacy of his tenure and that of the CFPB.
Categories
Alaska Arizona California Colorado Conservatism Courts Crime and Justice Culture Domestic Policy Economic Opportunity Economy Government Regulation Government Transparency and Accountability Legal and Judicial Markets and Finance Nevada New Mexico Oklahoma Political Thought Progressivism Public Opinion Texas The Constitution Top Issues Updates Utah
Newsmax: SCOTUS Decision Offers Americans Unrealized Gains
Originally published at newmax.com on November 4, 2024. The U.S. Senate investigation into Boeing’s safety practices and the FAA’s ineffective oversight revealed that Boeing, under pressure to prioritize production speed over safety, suffered quality control issues that endangered consumers. Despite these risks, the FAA’s overreliance on industry insiders failed to address Boeing’s deficiencies. The problem is not regulation; the […]
Patrick M. Brenner, recently appeared on the American Legal Record Podcast to discuss his views on the Consumer Financial Protection Bureau (CFPB) and its latest regulatory moves. In this insightful interview covered by American Credit News, Patrick delves into the core issues surrounding the CFPB’s recent circular on price comparison shopping sites and critically analyzes […]
Recent research has shown that health care consolidations not only lower costs for health care consumers but also improve multiple indicators of quality patient care.
Components of the Inflation Reduction Act have the very real potential of inflating drug prices with arbitrary price controls. Consumers will pay the price.